1. |
SCOTT AB,KENNEDY RA,STUBBS HA.Botulinum A toxic injection as a treatment for blepharospasm[J].Arch Ophthalmol,1985,103:347-350.
|
2. |
COHEN DA,SAVINO P,STERN MB,et al.Botulinum injection therapy for blepharospasm:a review and report of 75 patients[J].Chn Neuropharmacol,1986,9:415.
|
3. |
郝元涛,方积乾,李彩霞,等.世界卫生组织生存质量量表及其中文版介绍及其应用说明[J].国外医学社会医学分册,1999,16:118-122.
|
4. |
JOST WH,KOHL A.Botulinum toxin:evidencebased medicine criteria in blepharospasm and hemifacial spasm[J].Neurol,2001,248:S21-S24.
|
5. |
SCHANTZ EJ,JONSOS EA.Properties and use of botulinum toxin and other microtoxins in medicine[J].Mic Rev,1992,56:80.
|
6. |
SUPUTTITADA A,PHANTHUMCHINDA K,LOCHARERNKUL C,et al.Hemifacial spasm:results of treatment with low dose botulinum toxin injection[J].J Med Assoc Thail,2004,87:12051211.
|
7. |
SCHEIDT CE,SCHULLER B,RAYKI G,et al.Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm[J].Neurology,1996,47:43-45.
|
8. |
SCHNIDER P,BIRNER P,MORARU E,et al.Longterm treatment with botulinum toxin:dosage,treatment schedules and costs[J]. Wiener Klinische Wochenschrift,1999,111:59-65.
|
9. |
郝元涛,方积乾.世界卫生组织生存质量测定量表中文版介绍及其应用说明[J].现代康复,2000,4:1127-1129.
|
10. |
WHOQOL Group.Development of the World Health Organization WHOQOLBREF quality of life assessment[J].Psychol Med,1998,28:551-558.
|
11. |
钟萍,蒋毅. A型肉毒毒素治疗半侧面肌痉挛的临床疗效评价[J].现代生物医学进展,2006,6:44-45.
|